반응식
[NH2:1][C:2]1[N:7]=[C:6]2[C:8]([CH:11]3[CH2:16][CH2:15][N:14]([CH3:17])[CH2:13][CH2:12]3)=[CH:9][NH:10][C:5]2=[CH:4][CH:3]=1.[N+:18]([C:21]1[O:25][C:24]([C:26](Cl)=[O:27])=[CH:23][CH:22]=1)([O-:20])=[O:19]>>[N+:18]([C:21]1[O:25][C:24]([C:26]([NH:1][C:2]2[N:7]=[C:6]3[C:8]([CH:11]4[CH2:16][CH2:15][N:14]([CH3:17])[CH2:13][CH2:12]4)=[CH:9][NH:10][C:5]3=[CH:4][CH:3]=2)=[O:27])=[CH:23][CH:22]=1)([O-:20])=[O:19]참가 물질
3
실험 절차
Beginning with 0.010 gm (0.044 mMol) 5-amino-3-(1-methylpiperidin-4-yl)pyrrolo[3,2-b]pyridine and 0.0093 mL (0.053 mMol) 5-nitro-2-furoyl chloride, 0.010 gm (64%) of the title compound was prepared essentially by the procedure described in Example 7.
출처 및 근거
- ORD 기록
- ord-44291ffa148249a9b947574a9d84729a
- 출처 데이터셋
- uspto-grants-1999_12
- 특허 번호
- US05998622
연결된 노트
불러오는 중…